Evidence map›Paper›PMID 30042217›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Different opinion on the reported role of Poldip2 and ACSM1 in a mammalian lipoic acid salvage pathway controlling HIF-1 activation.

Peter S J Bailey, J Kalervo Hiltunen, Carol L Dieckmann, Alexander J Kastaniotis, James A Nathan

Abstract readLetterComment
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. METTL3-mediated m6A modification of ZNF384 promotes hepatocellular carcinoma progression by transcriptionally activating ACSM1.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Peter S J BaileyCambridge Institute for Medical Research, Department of Medicine, University of Cambridge, CB2 0XY Cambridge, United Kingdom.
J Kalervo HiltunenFaculty of Biochemistry and Molecular Medicine, University of Oulu, FIN-90014 Oulu, Finland.ORCID 0000-0002-3073-9602
Carol L DieckmannDepartment of Molecular and Cellular Biology, University of Arizona, Tucson, AZ 85721 dieckman@email.arizona.edu alexander.kastaniotis@oulu.fi jan33@cam.ac.uk.
Alexander J KastaniotisFaculty of Biochemistry and Molecular Medicine, University of Oulu, FIN-90014 Oulu, Finland; dieckman@email.arizona.edu alexander.kastaniotis@oulu.fi jan33@cam.ac.uk.ORCID 0000-0003-3624-9214
James A NathanCambridge Institute for Medical Research, Department of Medicine, University of Cambridge, CB2 0XY Cambridge, United Kingdom; dieckman@email.arizona.edu alexander.kastaniotis@oulu.fi jan33@cam.ac.uk.ORCID 0000-0002-0248-1632

Funding

Wellcome Trust 102770/Z/13/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hypoxia-Inducible Factor 1Thioctic AcidAnimalsAttitudeHypoxia-Inducible Factor 1Thioctic Acid

Identifiers

PMID30042217
PMCPMC6094132

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.